Biomedical science keeps pulling its greatest hits from smart, sometimes overlooked chemical families. Polyethylene Glycol Monooleate Sorbitol Ester traces its roots back to the efforts in the twentieth century to tame fatty acids for practical use in medicine and food. The formulation world chased after better emulsifiers and solved shelf life challenges, looking to keep things mixed, stable, and bioavailable. As pharmaceutical manufacturing became more demanding, attention shifted to blends that brought together the water-loving (hydrophilic) and oil-loving (lipophilic) sides of chemistry. Polyoxyethylene sorbitan esters, including this compound, weren't just clever—they gave industry the leverage to craft medicines, creams, and delivery systems where precise behavior made a huge difference between a functional product and a flop. Regulatory bodies in Europe, the United States, and Asia forced manufacturers to refine testing, purity, and sourcing, locking these compounds into pharma texts under BP, EP, and USP standards.
Somewhere between the fingerprint of nature and the logic of synthesis, Polyethylene Glycol Monooleate Sorbitol Ester combines fatty acid (often derived from oleic acid), polyethylene glycol chains, and a scaffold built on sorbitol. It slips into the pharma supply chain as a yellowish to amber, viscous liquid or semi-solid. Water answers only reluctantly to its presence, but alcohol and other solvents make quick friends. In everyday use, this substance stabilizes oil-in-water mixes, suspends actives, and fits in pharma formulations locked by global pharmacopoeia. The key: it bridges gaps between watery and oily components, helping creams and oral suspensions do their job. Names like PEG-400 Monooleate, Polysorbate 81 or the string of numbers manufacturers add, all point back to similar chemistry, with tweaks based on chain length and acid source.
A stubborn, nearly odorless liquid with an inviting yellow glow, Polyethylene Glycol Monooleate Sorbitol Ester tells a story through its melting point, specific gravity, and hydrophilic-lipophilic balance (HLB). Pour it out, and you get slight viscosity, a sign of the long polymer chains at play. Moisture chases but rarely catches up, as this molecule shrugs off water. It usually clocks in with an HLB around 4–8, tipping it toward the oil phase in dual systems—critical for slow-release jobs or oily actives. The saponification and acid numbers steer chemists during quality testing, setting expectations for reactivity and residual free acids. That steady, non-reactive streak makes it a go-to for dependable emulsions. Stability carries through in storage, so, handled right, it won't spoil easily even at room temp or typical warehouse conditions.
Quality means keeping a close eye on technical specs like average molecular weight, acid value, saponification value, and heavy metal limits. Regulatory compendia—British Pharmacopoeia (BP), European Pharmacopoeia (EP), United States Pharmacopeia (USP)—don't just suggest these numbers, they write them into law for anything tagged "Pharma Grade." Batch certificates include solvent residue, microbial contamination, and traceability all the way back to the original plant or synthetic source. For packaging, clear and tamper-proof labeling reflects not only what’s inside, but its status as a pharmaceutical excipient. This grows critical in applications like injectable or ophthalmic products, where even trace impurities cannot slip by unchecked.
Engineering a batch of Polyethylene Glycol Monooleate Sorbitol Ester means reacting sorbitol with ethylene oxide to create a polyethylene glycol backbone, then attaching the fatty acid (like oleic acid) in a controlled esterification process. Purification includes vacuum stripping and filtration to clear leftovers and color bodies, ensuring pharma-ready clean output. Real-time analytics check molecular weight distribution and determine when to halt or adjust the reaction. Operators keep a watchful eye on catalysts, temperature, and the stoichiometry between ingredients, knowing small changes can tip a batch from success to reject. End-to-end surveillance, often using validated in-line sensors, proves the point that good excipient chemistry requires precision and hands-on vigilance through every stage.
The functional chemistry of Polyethylene Glycol Monooleate Sorbitol Ester depends on tweaking the number of ethylene oxide units, the type of starting fatty acid, and sometimes post-reaction blending. While it resists most hydrolysis in mild conditions, acid or enzymatic challenge can cleave the ester or ether linkages, giving off sorbitol, PEG fragments, and fatty acids. Researchers push the molecule’s design, seeking derivatives that change water solubility or tweak HLB for new formulation needs. Its stability profile gets checked in the presence of proposed actives, temperature swings, and even stress conditions mimicking package aging. Crosslinking, conjugation, and other advanced modifications sometimes get play as teams hunt for delivery excipients that can withstand stomach acid or provide targeted drug release.
You won’t always spot this compound by just one name. Manufacturers and pharmacopeias list it as Polyoxyethylene (n) Sorbitan Monooleate, PEG-400 Monooleate, and sometimes as Polysorbate 81. Each synonym traces to the exact number of ethylene oxide units and the fatty acid used. The trade name often shows branding flair—some companies jazz up their labels with “-Pharma” or “-USP” suffixes, not always completely aligning with regulatory standards. On a global export document or customs manifest, digital databases tie all these names back to CAS numbers and regulatory dossiers, cutting through confusion when batches move from one country to another.
It’s easy to overlook workplace details, but handling this excipient safely means respecting both chemical and microbial hygiene. Pharma factories supplying European or US buyers adhere to GMP—Good Manufacturing Practice. Operators suit up, use proper air handling, and log every stir and sample. Polyethylene Glycol Monooleate Sorbitol Ester rarely brings acute toxicity, but the focus shifts to residual solvents, leachables, and process contaminants. Material Safety Data Sheets (MSDS) insist on gloves, eye protection, and proper spill management. While most excipients get widely used in food and drugs, companies document every possible risk—hypersensitivity, cumulative exposure, trace allergens—before any product touches a patient. Any lapsed batch record or equipment mismatch quickly draws scrutiny under audit, building a safety culture that doesn’t take shortcuts.
Ask most formulation chemists, and they're likely to mention Polyethylene Glycol Monooleate Sorbitol Ester as a team player across dosage forms—tablets, creams, ophthalmics, suspensions. In oral medicines, it stabilizes active ingredients that don't want to dissolve, or it softens granules for easier swallowing. Topical drugs get spreadability and skin absorption benefits from its surfactant backbone. Sterile preparations like eye drops rely on its purity and predictable behavior under sterilization. Medical device coatings sometimes turn to this ester for its film-forming strengths. Beyond pharma, you find it in vitamin supplements, nutraceuticals, and even select food items—provided the grade and traceability meet regulator demands. Its value comes not just from what it can do, but from how consistently it performs in tightly regulated environments.
Ongoing research around Polyethylene Glycol Monooleate Sorbitol Ester keeps circling back to drug delivery. Scientists experiment with tweaks to chain length and the fatty acid tail, hoping to tune release rates or improve payload solubility. New analytical methods, from advanced chromatography to NMR and mass spectrometry, speed up the screening of by-products and trace contaminants. The focus now includes compatibility with biologic drugs—antibodies, RNA therapeutics—where the traditional rules get tested. Collaboration with packaging experts helps predict interactions over longer shelf lives. A big chunk of R&D funding in this field now deals with understanding behavior under stress, exposure to light, or mechanical agitation, tying back to global supply and ambient storage. Development cycles for new drugs can stall if an excipient throws a stability curveball, so chemists treat these studies as mission-critical, not nice-to-have.
Toxicology on excipients stays a moving target, always pressing deeper as therapy windows tighten and regulatory science advances. Polyethylene Glycol Monooleate Sorbitol Ester generally sees a clean bill of health at the doses used in medicine, but real safety comes from chronic exposure studies—including animal models and monitored human use. Investigators watch for organ accumulation, subtle metabolic impacts, and allergy signals, especially when products launch outside their traditional markets. Published toxicity reviews flag the rare cases of hypersensitivity or digestive upset, usually traced to impurities or excessive inclusion rates. Regulators demand robust evidence before approving new delivery methods—injectables, implants—where any minute leaching from the excipient could matter. Safety always circles back to purity in manufacture and thorough batch qualification, never just the chemical itself.
Pharmaceutical science doesn’t stand still: patient expectations keep pushing for faster, safer, and more personalized therapies. Polyethylene Glycol Monooleate Sorbitol Ester remains key as drug development moves toward more complex molecules and harder-to-formulate drugs. Synthetic biology, green chemistry, and automation will likely influence how manufacturers make and scale this excipient. With more biologics entering the market, demand for excipients that won’t destabilize proteins or interact in unpredictable ways will climb. Environmental concerns will shape excipient sourcing and production, prompting efforts to cut waste, shrink water and solvent footprints, and trace plant-based inputs. The future may also bring regulatory shifts—more transparency in labeling, required lifecycle toxicology screening, and real-time digital tracking from factory to pharmacy. For companies navigating this landscape, the focus will rest not just on basic compliance but on exceeding standards, ensuring their excipients stand up to scrutiny wherever medicines travel in the world.
Behind many pills and syrups sits an unsung hero: Polyethylene Glycol Monooleate Sorbitol Ester. Pharmacists and researchers see it as a bridge between ingredients that otherwise don’t “get along”—essentially, a strong emulsifier. Think of mixing oil and water; they fight each other without a peacemaker. In drug development, this ester brings ingredients together in a way that allows medicines to work as intended, whether swallowed, injected, or rubbed on the skin.
Half the challenge in drug design comes down to solubility. Poorly soluble drugs can’t get absorbed well after swallowing, so their benefit drops. Polyethylene Glycol Monooleate Sorbitol Ester, approved by leading pharmacopeias like BP, EP, and USP, answers this hurdle. It increases water-loving (hydrophilic) and fat-loving (lipophilic) balance in active compounds. For example, certain heart drugs lose effectiveness because the body can’t absorb them fast enough. This ester helps those medicines become “available” to the body, pushing up the benefits for patients who rely on every milligram the pill contains.
I’ve spent time on both sides of the pharmacy counter. Patients expect that every pill inside a bottle works the same way. This ingredient locks together a drug’s components so each tablet dissolves at the right pace, delivering predictable results. Without it, you’d see one tablet racing through your system and another dragging its feet. Families with young kids, people struggling with chronic pain, or the elderly can’t afford guesswork in medication timing. Consistency keeps trust in our healthcare system intact.
The pharmaceutical world doesn’t stand still. Researchers lean on Polyethylene Glycol Monooleate Sorbitol Ester to explore new delivery forms—liquids for kids, gels for people with trouble swallowing, even sustained-release patches. The same qualities that make one form stable often translate across to others. My time working with children’s liquid medicines hammered home how much flavor masking and dispersion matter. This ester subtly boosts taste-masking while preventing contents from clumping, making medicine less of a battle for children and parents alike.
Doctors, pharmacists, and patients all expect a high safety bar for pharmaceutical ingredients. Regulators in Europe, the US, and elsewhere make sure that anything coming near medicine batches meets strict guidelines. Polyethylene Glycol Monooleate Sorbitol Ester achieves global standards for purity, safety, and performance. I’ve worked alongside quality control teams who scrutinize each batch for unwanted chemicals or impurities. It’s exhausting work, but public health leaves no room for shortcuts—something patients rarely see or hear about.
Modern drug-makers face pressure to improve efficiency, reduce waste, and source sustainable ingredients. Polyethylene Glycol Monooleate Sorbitol Ester already ticks several boxes, thanks to its versatility. Still, the push for “greener” supply chains and biodegradable carriers is heating up. Pharmaceutical chemists keep a close eye on new variations and blending techniques. These efforts aren’t just about market competition; they directly support safer, more accessible medicines for communities everywhere—something that matters far beyond the walls of a lab or pharmacy.
Nobody likes a product that doesn't fit. Whether we're talking about industrial components or electronics, size matters because it influences compatibility and performance. Tighter tolerances keep everything running smooth. For example, a gear that’s even one millimeter off can cause noise or wear, leading to expensive downtime. Digital calipers and laser measurement tools give reliable readings, and records should back up those numbers. A clear spec sheet with length, width, thickness, and weight can prevent confusion before the product ships.
Material isn’t just a detail—it forms the backbone of durability and safety. Stainless steel components need high chromium and nickel content to resist rust and offer strength under heavy loads. If there’s too much sulfur or phosphorus, cracking may appear after only a few cycles. Food-grade plastics must meet FDA regulations to stay safe in contact with food, while electronics require RoHS-compliance to reduce lead and mercury. Nobody wants surprises after installation. Certifications from organizations like ASTM or ISO offer confidence that the batch matches the claims on the datasheet.
Real-world use often pushes products harder than tests in controlled labs. Accelerated aging proves useful to check if seals survive years of wear or if batteries last through thousands of cycles. In the world of electronics, thermal cycling finds weak solder joints before the customer does. Data should include pass/fail criteria: temperature ranges, number of cycles completed, and any signs of failure. Companies that add traceability codes or batch numbers make troubleshooting easier. If a problem pops up, they can track down the issue and fix it fast, limiting losses.
Surface finish affects both looks and how parts work together. Machined metal parts must hit certain roughness values so they don’t snag or seize. Cleanliness goes deeper—contaminants like oil, metal dust, or packaging fibers can lead to bigger problems down the line. Proper cleaning steps, from ultrasonic baths to air knives, keep products out of the reject pile. Quality inspectors back these checks with inspection reports and, if needed, samples that show both good and bad finishes for quick comparison.
Cutting corners on paperwork leads to chaos. Detailed records show who made the product, which batch went through which line, and who signed off at each inspection point. For pharmaceuticals, this means complying with Good Manufacturing Practices—without those records, it’s impossible to verify safety. Barcode systems and QR codes allow manufacturers and customers to look up critical details instantly. Customers and inspectors often ask for certificates of analysis, compliance sheets, or safety data sheets before moving forward.
No system catches everything on the first try. Statistical sampling, visual checks under bright lights, and automated machine vision systems all play a part. What sets great manufacturers apart is a focus on fixing root causes after something slips through. Plant managers who track problems with regular audits or customer returns spot trends before they get out of hand. Encouraging honest feedback from both line workers and customers often drives the best changes.
Specifications and quality standards rely on clear communication, honest measurements, and a commitment to catching mistakes before they leave the factory. Real experience teaches that control isn’t just a one-time event—it’s a process built on trust and action.
Working in pharmaceutical manufacturing taught me that pharmacopeia compliance is more than a paperwork exercise. Everyone in the supply chain, from chemists to warehouse staff, relies on rock-solid assurance about what goes into each batch. The British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) all set out clear rules for quality, safety, and purity. Each set of requirements demands rigorous attention to detail.
Laboratories deal with long lists of specifications—identity, purity, potency, microbial limits, and even packaging. Over the years, each update to these standards brings shifts in acceptable limits for impurities or changes in test methods. Forgoing up-to-date compliance isn’t a shortcut; it’s an invitation to wasted product and regulatory headaches. Regulators and buyers want proof—certificates of analysis, clear batch records, and traceable raw materials.
Pharmacists and doctors trust that any approved drug they prescribe has passed these quality hurdles. Patients never see the analytical chemistry behind a pill or an injection, but their health depends on that invisible work. An out-of-specification product risks not just legal sanctions but people’s lives. Buying from a non-compliant source could mean introducing unknown impurities, inconsistent levels of active ingredients, or even contamination.
My first few months working with quality assurance convinced me of the difference that meticulous compliance makes. I watched shipments held at the border because documentation failed to match BP or USP specs. I’ve seen a fail in a water content test trigger recalls costing millions. Without alignment to pharmacopeia rules, a company risks market access in Europe, the US, or the UK. It turns into a barrier for global supply chains, patent filings, and even government tenders.
Claims of compliance aren’t enough. Manufacturers should show validation records, stability studies, method suitability data, and up-to-date reference standards from recognized sources. Potency tests, impurity profiles, dissolution rates—all these numbers need matching against current versions of BP, EP, and USP monographs. For example, as of 2023, the USP required nitrosamine impurity testing for an expanded list of ingredients, raising the bar for analytical testing.
Distributors must demand more than a generic certificate. Site audits, requests for original test records, and direct communication with quality departments reveal how closely a factory tracks those monograph requirements. In my experience, outfits willing to open up their processes and supply raw testing data inspire more confidence. Vendors hiding behind vague paperwork or unwilling to answer direct questions often harbor deeper problems.
Fixing compliance gaps often takes more than updating a test method. It might mean investing in new equipment, retraining analysts, or overhauling raw material qualification procedures. In one plant, we needed a full six months to shift to an updated USP identification method, and the expense paid for itself by stopping potential product holds. Setting up consistent supplier audits and building relationships with reference standards labs helped remove a lot of the guessing from my daily workload.
Education continues to drive improvement. Regulatory harmonization efforts, such as the ICH guidelines, push labs to keep up with changing expectations. Networking with peers showed me small companies can meet tough international requirements, especially if they tap into industry associations and open channels with authorities. Transparency with failures and corrective action reporting often builds more trust than chasing a spotless record.
Most of us won’t see Polyethylene Glycol Monooleate Sorbitol Ester scribbled on a box of medicine or supplement. Still, those in the know recognize it by trade names, often as an emulsifier or stabilizer. I’ve seen it earn its keep in pharmaceutical formulations, especially where two things don’t blend easily — like oil and water. It gets tucked into tablet coatings, creams, and even some liquid suspensions, making a difference without making headlines.
Getting medicine to work as intended takes more than stuffing a drug inside a tablet. Many drugs don’t mix well with bodily fluids or break down too quickly. Some slip through the digestive tract without delivering much benefit. Polyethylene glycol monooleate sorbitol ester helps those medicines make it past these hurdles. Working with this type of surfactant means drugs that normally dissolve poorly find better ways into the bloodstream. It acts almost like a sports coach, ushering stubborn active ingredients out onto the field so they can actually play the game.
I’ve watched people return to the pharmacy because a cream felt too greasy, separated in the tube, or refused to soak in. With the right stabilizers and emulsifiers, those problems fade away. Adding this sorbitol ester gives creams a texture people trust. Lotions get smoother, ointments less tacky. Medicines spread without leaving slick residues or separating overnight. This sounds like a small touch, but it matters — especially for skin treatments people rely on every day.
Syrups and suspensions for kids, or adults who struggle with pills, need consistent texture and dose. Without the proper agent, medicine sinks, sticks to the bottle, or clumps together. Adding a touch of this PEG-based ester keeps particles suspended longer. Grandma shakes the bottle and pours out an even dose instead of sludge or mostly sugar water. The fact that parents can give a full dose even after the bottle’s been in the cupboard for weeks isn’t an accident — it’s careful formulation with a helper like this ester.
Many modern medications focus on diseases that demand better delivery systems. I’ve seen how this ester increases absorption of fat-soluble vitamins and lipid-based drugs. It isn’t only about getting the active ingredient inside but making sure it does the job on time, every time. By improving how well medicines travel through the gut, this ingredient supports treatments for conditions like epilepsy or hormone disorders, where dose reliability carries real consequences.
Years ago, excipients took a backseat in pharmaceutical conversations. These days, regulators and experts keep a close eye on safety and quality. Polyethylene glycol monooleate sorbitol ester has earned a strong reputation, but every new use involves careful review — toxicology data, interaction studies, and patient feedback. Clean labeling trends push makers to share ingredient lists openly. Some patients call for plant-based or hypoallergenic alternatives, opening demand for more innovation in this category.
I’ve seen firsthand how a tweak in the excipient lineup transforms a stubborn formulation into something reliable and patient-friendly. That’s the path worth following: using well-studied ingredients, listening to user feedback, and pushing for transparency in every step. For all its scientific complexity, the story comes back to people and their need for safe, simple, and effective medicine.
Polyethylene Glycol Monooleate Sorbitol Ester, known in many pharmaceutical labs for its role as an emulsifying agent, does a lot more than just sit quietly on a supply shelf. It keeps drugs stable, helps blend ingredients, and reduces the risk of those tricky separation issues in suspensions and creams. Keeping it in top condition makes a real difference in the performance of finished formulations. I’ve seen how even minor neglect can lead to product recalls or wasted batches—which no pharmacist or manufacturer ever enjoys dealing with.
I’ve learned from pharmacists and manufacturers that location and environment can make or break the quality of a pharmaceutical-grade excipient. The best practice involves keeping the container sealed tightly in a cool, dry space. Moisture may spoil the product, so storing it away from steam lines, sinks, or spaces prone to humidity helps. Exposure to excessive heat can shift the consistency and limit effectiveness, so keeping it below 30°C (86°F) keeps the ester functioning as intended.
Shelves should be sturdy, clean, and away from direct sunlight. Some folks believe light doesn’t impact all excipients, but bright or direct light may not be a gamble worth taking for a premium pharmaceutical grade. I recommend using dark or opaque containers, which cut down light exposure and contamination risk. Label every container with the date of receipt and opening, so you can cycle the stock efficiently to use the oldest first. That avoids discovering expired material when you’re behind deadlines.
While it sounds obvious, proper handling starts with personal safety. Before touching the ester, put on gloves and splash protection for eyes. Even though this excipient remains non-toxic at the levels used in medicine, trace residues on skin can cause irritation for sensitive folks. After one colleague touched some while distracted, she reported a mild rash—it cleared up quickly, but now she won’t skip PPE.
Keep the work area clean and free from dust or spills, as cross-contamination may spoil the next formulation. Always pour or scoop the material slowly to avoid spreading fine particles. Spillage happens—if it does, sweep up the solid carefully and wash the area with mild detergent and water. Never flush large amounts down the drain, as disposal rules can vary depending on country or region. Always check your local waste guidelines, and contact hazardous waste disposal services if you’re unsure.
Pharma-grade materials also come with supporting paperwork, including Certificates of Analysis and spec sheets. Store these records in a central repository—digital or physical—so anyone can quickly check the origins and quality checks completed. Rushed or chaotic record-keeping creates headaches, especially during audits or investigations.
Each time a container gets opened, fresh air enters, bringing potential for moisture or microbial contamination. If you take out only what you need, and seal the lid right after, the remaining product stays fresher. Avoid transferring the ester to smaller containers unless they’re sterile and clearly labeled. In my experience, careless relabeling or using old jars has caused more confusion than convenience.
Quality assurance teams should schedule routine checks on larger stockpiles. Visual inspections for clumping, discoloration, or separation offer early signals when the material isn’t what it should be. I’ve walked through enough storerooms to know that a simple check once a month keeps expensive mistakes off the books.
Strict attention to storage and handling isn’t bureaucracy—it keeps the medicine effective and consistent for everyone who uses it. Learning from missteps and sticking to thorough routines proves far less costly than dealing with compromised batches. If every staff member in a lab or warehouse follows smart storage rules and careful handling, the quality of finished drugs remains much more reliable.
Names | |
Preferred IUPAC name | Sorbitan mono[(Z)-octadec-9-enoate] polyethylene glycol ether |
Other names |
PEG Monooleate Sorbitan Ester Polyoxyethylene Sorbitan Monooleate Sorbitan Monooleate Ethoxylated Polysorbate Tween Polyoxyethylene (20) sorbitan monooleate |
Pronunciation | /ˌpɒliˈɛθɪliːn ɡlaɪˈkɒl ˌmɒnoʊˈoʊleɪt ˈsɔːrbɪtɒl ˈɛstər/ |
Identifiers | |
CAS Number | 9005-66-7 |
3D model (JSmol) | Sorry, I cannot provide the '3D model (JSmol)' string for 'Polyethylene Glycol Monooleate Sorbitol Ester BP EP USP Pharma Grade' as it is a complex mixture and does not have a single defined molecular structure suitable for a JSmol string representation. |
ChEBI | CHEBI:53497 |
ChEMBL | CHEMBL1201475 |
ChemSpider | 3059402 |
DrugBank | DB11024 |
ECHA InfoCard | EC#: 500-018-3 |
EC Number | [9005-66-7] |
Gmelin Reference | 1397691 |
KEGG | C01744 |
MeSH | D02WJ3F43G |
PubChem CID | 12362213 |
RTECS number | TWG8050000 |
UNII | G0761GPI27 |
UN number | UN3082 |
CompTox Dashboard (EPA) | C529262 |
Properties | |
Chemical formula | C64H124O24 |
Molar mass | 987.4 g/mol |
Appearance | Light yellow to amber oily liquid |
Odor | Odorless |
Density | 1.06 g/cm³ |
Solubility in water | Insoluble in water |
log P | 2.9 |
Vapor pressure | Negligible |
Basicity (pKb) | pKb: 5.4 |
Refractive index (nD) | 1.465 - 1.475 |
Viscosity | 300 to 500 cP at 25°C |
Dipole moment | 2.3–2.6 D |
Pharmacology | |
ATC code | A06AD15 |
Hazards | |
Main hazards | May cause eye, skin, and respiratory irritation. |
GHS labelling | GHS07, GHS hazard statement: H315, H319, H335 |
Pictograms | GHS07,GHS05 |
Precautionary statements | Precautionary statements: P264, P280, P305+P351+P338, P337+P313, P501 |
NFPA 704 (fire diamond) | 1-1-0-0 |
Flash point | > 285°C |
Autoignition temperature | > 357°C |
LD50 (median dose) | LD50 (median dose): >25 g/kg (oral, rat) |
NIOSH | TRIETHYLENE GLYCOL MONOOLEATE: 9005-70-3 (NIOSH: TQ4100000) |
PEL (Permissible) | PEL not established |
REL (Recommended) | 0.1% to 10% w/w |
Related compounds | |
Related compounds |
Polyethylene Glycol Sorbitan Monooleate Polysorbate 80 Polyoxyethylene Sorbitan Esters Sorbitol Oleic Acid Polyethylene Glycol 400 Monooleate |